Roche Kulmbach GmbH

Roche Kulmbach GmbH is Roche's Center of Excellence for the discovery and development of a new class of therapeutics based on the principle of RNA interference (RNAi). RNAi is a natural process to selectively silence endogenous genes and is mediated by Small Interfering RNAs (siRNAs). Roche Kulmbach GmbH uses synthetic siRNAs to specifically silence disease-associated genes. This universal approach is applied to develop novel therapeutics for the treatment of oncological, respiratory and metabolic diseases.

Further Information: http://www.roche-kulmbach.de/portal/eipf/de/RocheKulmbach/RocheKulmbach